Business Context and Reporting Period
Company: MacroGenics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 31, 2015
Event: Entry into a Material Definitive Agreement (Lease Assignment and Amendment)
On July 31, 2015, MacroGenics, Inc. entered into a transaction to lease approximately 122,600 square feet of mixed-use office, laboratory, and manufacturing space in Rockville, Maryland, to serve as its primary headquarters. The agreement involves an assignment and assumption of rights from the J. Craig Venter Institute, Inc. (JCVI) under an existing lease with BMR-Medical Center Drive LLC (BMR), alongside a concurrent amendment.
Key Financial Metrics and Lease Terms
Lease Commencement: January 1, 2016
Lease Term: 7 years, with two options to extend for an additional 7 years each.
Upfront Payments Received: $2.1 million from JCVI and $3.1 million from BMR.
Security Deposit Required: $0.9 million.
Assets Acquired: Office furniture, laboratory equipment, and a generator.
| Period | Rent (in thousands) |
|---|---|
| Commencement through Dec 31, 2016 | $1,768 |
| Jan 1, 2017 through Dec 31, 2017 | $1,821 |
| Jan 1, 2018 through Dec 31, 2018 | $1,876 |
| Jan 1, 2019 through Dec 31, 2019 | $1,932 |
| Jan 1, 2020 through Dec 31, 2020 | $1,971 |
| Jan 1, 2021 through Dec 31, 2021 | $2,575 |
| Jan 1, 2022 through Term Expiration | $2,636 |
Note: Rent figures exclude operating costs and property taxes, for which the Company is responsible. 2016 and 2020 figures are annualized or total amounts subject to pro-rata adjustments.
Material Changes and Operational Impact
This filing represents a significant expansion of the Company's physical footprint, transitioning to a dedicated headquarters facility that consolidates office, laboratory, and manufacturing operations. The Company will assume the lease obligations previously held by JCVI, with rent payments commencing in 2016. The agreement includes rights of first offer to purchase the building and lease adjacent space.
Guidance, Risks, and Contingencies
Management Commentary: The filing does not provide specific forward-looking financial guidance or management commentary beyond the description of the lease terms.
Risks and Contingencies:
- The Company is responsible for operating costs and property taxes in addition to base rent.
- Subleasing any portion of the premises or making changes to the property requires landlord (BMR) approval.
- The full legal description of rights and obligations is contained in the Second Amendment to Lease, to be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2015.
Key Facts for Investor Verification
- Verify the total capital expenditure required for the $0.9 million security deposit and any fit-out costs for the new facility.
- Confirm the impact of the new lease obligations on the Company's future cash flow and liquidity starting January 1, 2016.
- Review the upcoming Form 10-Q (Q3 2015) for the full text of the Second Amendment to Lease to understand specific covenants and termination rights.
- Assess the strategic rationale for acquiring the specific mix of office, lab, and manufacturing space relative to the Company's pipeline.